Sanofi

YTD

ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines, vaccines franchises, support, and corporate functions 1973 and is headquartered in Paris, France.

CEO

Belén Garijo López

CEOBelén Garijo López

Employees

76,493

Employees76,493

Headquarters

Paris, Ile-de-France

HeadquartersParis, Ile-de-France

Founded

1973

Founded1973

Employees

76,493

Employees76,493

SNY Key Statistics

Market cap

117.37B

Market cap117.37B

Price-Earnings ratio

24.81

Price-Earnings ratio24.81

Dividend yield

3.65%

Dividend yield3.65%

Average volume

4.63M

Average volume4.63M

High today

$48.66

High today$48.66

Low today

$47.99

Low today$47.99

Open price

$48.51

Open price$48.51

Volume

1.68M

Volume1.68M

52 Week high

$52.67

52 Week high$52.67

52 Week low

$39.07

52 Week low$39.07

SNY News

Simply Wall St 6h

How Investors Are Reacting To Nurix Therapeutics CMO Appointment

Nurix Therapeutics appointed Arati V. Rao, M.D. as chief medical officer and reported that partner Sanofi ended the SAR448272 STAT6 degrader program, removing a...

TipRanks 8h

Sanofi Earnings Call Signals Growth Despite Pipeline Risks

Sanofi SA ((SNY)) has held its Q3 earnings call. Read on for the main highlights of the call. Sanofi’s third-quarter earnings call carried a strongly positive...

Simply Wall St 1d

Nurix Therapeutics Could Be 55% Undervalued After Sanofi Ends Phase 1 Program

Nurix Therapeutics (NRIX) shares are in focus after Sanofi ended its Phase 1 trial for SAR448272, which cuts off potential milestones and royalties tied to that...

Analyst ratings

60%

of 10 ratings

Buy

60%

Hold

40%

Sell

More SNY News

TipRanks 2d

Sanofi price target raised to EUR 93 from EUR 78 at Citi

Citi analyst Graham Parry raised the firm’s price target on Sanofi (SNY) to EUR 93 from EUR 78 and keeps a Neutral rating on the shares. Published first on The...

TipRanks 2d

Sanofi Updates Infant Pompe Disease Study: What Investors Should Know

Sanofi (SNYNF) announced an update on their ongoing clinical study. Study Overview: Sanofi’s study, officially titled “A Prospective Observational Study to Des...

The Wall Street Journal 2d

Health Care Roundup: Market Talk

george frey / Reuters The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET....

TipRanks 3d

Sanofi Discloses October 31, 2026 Share and Voting Rights Figures

An update from Sanofi ( (FR:SAN) ) is now available. Sanofi, a French société anonyme with share capital of EUR 2,415,546,786, reported that on 31 October 2026...

TipRanks 3d

Sanofi Updates Long-Term Frexalimab Study as Investors Watch Multiple Sclerosis Pipeline

Sanofi SA (SNY) announced an update on their ongoing clinical study. Study Overview: Sanofi’s Phase 3 study, officially titled “A Phase 3 Extension Study to In...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.